With in vitro data supporting a functional role for CHRNA7 activity in immune cell activation (Fig. 3), and the tumor permissive phenotype of CHRNA7KO mice (Fig. 1), we performed a combination of immunohistochemistry and flow cytometry to localize and quantify tumor-associated immune cells. The gene discussed is CHRNA7; the disease is neoplasm.